New cholera vaccine trial aims to protect south africans of all ages
NCT ID NCT07304284
First seen Jan 11, 2026 · Last updated May 05, 2026 · Updated 17 times
Summary
This study tests a new oral cholera vaccine (Biovac OCV-S) to see if it works as well as a currently approved vaccine (Euvichol-Plus). About 2,824 healthy people aged 1 to 45, plus some adults living with HIV, will receive two doses. Researchers will check immune response and safety over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLERA VACCINATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Perinatal HIV Research Unit (PHRU)
RECRUITINGJohannesburg, Gauteng, 1862, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SAMRC Chatworth CRS
RECRUITINGDurban, KwaZulu-Natal, 4092, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SAMRC Isipingo CRS
NOT_YET_RECRUITINGDurban, KwaZulu-Natal, 4110, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Synergy Biomed Research Institute
NOT_YET_RECRUITINGDurban, Eastern Cape, 5201, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit
NOT_YET_RECRUITINGJohannesburg, Gauteng, 1862, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.